RESULTS
Out of 82 screened outpatients with SUD under MMT program, 60 individuals were enrolled in the clinical trial and randomly assigned to both treatment and control groups to receive NAC or placebo, respectively (30 individuals to each group). In the control group, seven people discontinued the clinical trial due to personal reasons, and positive cannabis urine tests. In the intervention group, nine people revoked their consent. Hence, 44 individuals (intervention [Summary of patient flow diagramPatient characteristics with SUD under MMTData are mean ± SDs and percentage.Obtained from independent Obtained from Pearson Chi‐square test.